-
New Data on Extended-Release Amantadine for Dyskinesia
April 26, 2017
… or so, we've told you about a dyskinesia drug that is advancing toward U.S. Food and Drug Administration (FDA) … announced new data for this therapy, an extended-release formulation of amantadine designed to be taken once … EASE LID 3. Consistent with previous reported results, the company's compound ( ADS-5102) was effective in reducing …
-
Jake’s Ride Announces New Dates and Events
September 10, 2015
… Jake’s Ride will return to the Short Hills, NJ community to raise funds and awareness for The Michael J. Fox Foundation. Founded in 2008, Jake’s … of the thousands of dystonia patients who will benefit from the invaluable research efforts the event has …
-
-
Searching for and Targeting Calcium Channels that Control Alpha-synuclein Release
… Study Rationale: Being the primary component of Lewy bodies -- protein clumps that are the … critical components of the process of alpha-synuclein release from the cell. We ultimately aim to prevent … while preserving the small amount of the protein necessary for normal brain functioning. Hypothesis: We previously …
-
Reactions to Apple's ResearchKit Announcement Reverberate Around Web
March 12, 2015
… the launch of ResearchKit and a series of apps designed to gather clinical data through your iPhone. The Michael J. … in multiple articles as the news reverberated around the Web. Excerpts are below: Time.com: How Apple's New Health App Could be Used – or Abused …
-
Drug Approval Application Decision Delayed for New Extended Release Carbidopa-Levodopa Capsule
October 13, 2012
… on their New Drug Application , an important final step before a drug can go to market, by October 21. The new … for a ruling is January 21. Rytary is an improved extended release capsule formulation of carbidopa-levodopa that has … and a half less "off-time" per day when taking the drug, as compared with carbidopa-levodopa plus entacapone. There is …